Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079078209> ?p ?o ?g. }
- W2079078209 endingPage "405" @default.
- W2079078209 startingPage "396" @default.
- W2079078209 abstract "Hematopoietic stem cell transplantation (HSCT) from human leukocyte antigen (HLA) haploidentical family donors is a promising therapeutic option for high-risk hematologic malignancies. Here we explored in 121 patients, mostly with advanced stage diseases, a sirolimus-based, calcineurin-inhibitor-free prophylaxis of graft-versus-host disease (GvHD) to allow the infusion of unmanipulated peripheral blood stem cell (PBSC) grafts from partially HLA-matched family donors (TrRaMM study, Eudract 2007-5477-54). Conditioning regimen was based on treosulfan and fludarabine, and GvHD prophylaxis on antithymocyte globulin Fresenius (ATG-F), rituximab and oral administration of sirolimus and mycophenolate. Neutrophil and platelet engraftment occurred in median at 17 and 19 days after HSCT, respectively, and full donor chimerism was documented in patients’ bone marrow since the first post-transplant evaluation. T-cell immune reconstitution was rapid, and high frequencies of circulating functional T-regulatory cells (Treg) were documented during sirolimus prophylaxis. Incidence of acute GvHD grade II–IV was 35%, and occurrence and severity correlated negatively with Treg frequency. Chronic GvHD incidence was 47%. At 3 years after HSCT, transpant-related mortality was 31%, relapse incidence 48% and overall survival 25%. In conclusion, GvHD prophylaxis with sirolimus–mycophenolate–ATG-F–rituximab promotes a rapid immune reconstitution skewed toward Tregs, allowing the infusion of unmanipulated haploidentical PBSC grafts." @default.
- W2079078209 created "2016-06-24" @default.
- W2079078209 creator A5004153853 @default.
- W2079078209 creator A5006672507 @default.
- W2079078209 creator A5006906416 @default.
- W2079078209 creator A5010579045 @default.
- W2079078209 creator A5012911614 @default.
- W2079078209 creator A5019796416 @default.
- W2079078209 creator A5022712318 @default.
- W2079078209 creator A5025505120 @default.
- W2079078209 creator A5026667594 @default.
- W2079078209 creator A5027372921 @default.
- W2079078209 creator A5027599215 @default.
- W2079078209 creator A5029127045 @default.
- W2079078209 creator A5032192705 @default.
- W2079078209 creator A5036175544 @default.
- W2079078209 creator A5036204725 @default.
- W2079078209 creator A5039245100 @default.
- W2079078209 creator A5039861777 @default.
- W2079078209 creator A5044577073 @default.
- W2079078209 creator A5045261121 @default.
- W2079078209 creator A5045645624 @default.
- W2079078209 creator A5048805184 @default.
- W2079078209 creator A5050306126 @default.
- W2079078209 creator A5050682361 @default.
- W2079078209 creator A5054335870 @default.
- W2079078209 creator A5055304980 @default.
- W2079078209 creator A5057107134 @default.
- W2079078209 creator A5057333997 @default.
- W2079078209 creator A5061017697 @default.
- W2079078209 creator A5061333691 @default.
- W2079078209 creator A5067292924 @default.
- W2079078209 creator A5074043746 @default.
- W2079078209 creator A5074636784 @default.
- W2079078209 creator A5075416361 @default.
- W2079078209 creator A5076929140 @default.
- W2079078209 creator A5082083571 @default.
- W2079078209 creator A5086372056 @default.
- W2079078209 creator A5087647636 @default.
- W2079078209 date "2014-06-04" @default.
- W2079078209 modified "2023-10-15" @default.
- W2079078209 title "Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors" @default.
- W2079078209 cites W1530764705 @default.
- W2079078209 cites W1590178524 @default.
- W2079078209 cites W1973617793 @default.
- W2079078209 cites W1979849861 @default.
- W2079078209 cites W1981690705 @default.
- W2079078209 cites W1983821870 @default.
- W2079078209 cites W1991140047 @default.
- W2079078209 cites W2000653963 @default.
- W2079078209 cites W2005256320 @default.
- W2079078209 cites W2011660868 @default.
- W2079078209 cites W2017908149 @default.
- W2079078209 cites W2021378114 @default.
- W2079078209 cites W2022956462 @default.
- W2079078209 cites W2022957937 @default.
- W2079078209 cites W2029070864 @default.
- W2079078209 cites W2036736974 @default.
- W2079078209 cites W2039334806 @default.
- W2079078209 cites W2045475405 @default.
- W2079078209 cites W2046689400 @default.
- W2079078209 cites W2053278212 @default.
- W2079078209 cites W2057057251 @default.
- W2079078209 cites W2061878111 @default.
- W2079078209 cites W2073045132 @default.
- W2079078209 cites W2074181748 @default.
- W2079078209 cites W2077173355 @default.
- W2079078209 cites W2083591652 @default.
- W2079078209 cites W2093107492 @default.
- W2079078209 cites W2099384160 @default.
- W2079078209 cites W2099694564 @default.
- W2079078209 cites W2104294740 @default.
- W2079078209 cites W2110641805 @default.
- W2079078209 cites W2112611192 @default.
- W2079078209 cites W2115721890 @default.
- W2079078209 cites W2116460145 @default.
- W2079078209 cites W2121779980 @default.
- W2079078209 cites W2121950548 @default.
- W2079078209 cites W2125779795 @default.
- W2079078209 cites W2126021331 @default.
- W2079078209 cites W2128812336 @default.
- W2079078209 cites W2130040182 @default.
- W2079078209 cites W2142699023 @default.
- W2079078209 cites W2143034151 @default.
- W2079078209 cites W2147068163 @default.
- W2079078209 cites W2152515293 @default.
- W2079078209 cites W2152591595 @default.
- W2079078209 cites W2160666689 @default.
- W2079078209 cites W2317548431 @default.
- W2079078209 cites W2317642686 @default.
- W2079078209 cites W2420987345 @default.
- W2079078209 doi "https://doi.org/10.1038/leu.2014.180" @default.
- W2079078209 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24897508" @default.
- W2079078209 hasPublicationYear "2014" @default.
- W2079078209 type Work @default.
- W2079078209 sameAs 2079078209 @default.
- W2079078209 citedByCount "105" @default.
- W2079078209 countsByYear W20790782092014 @default.